Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Understand when to choose cash savings over investments. Gain insights to help you make strategic financial decisions for stability.
25,959 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Hewlett Packard Enterprise faces a pivotal Q2 print after the market closes, with an AI backlog fueling optimism and ...
When a new Fed chair takes the podium, investors watch not just for rate hints but for what isn’t said. This piece br...
Tesla delivers a long-awaited autonomy milestone with unsupervised robotaxi rides in Dallas and Houston, sending TSLA...
Geopolitical conflicts are upending the classic playbook for U.S. stocks. The S&P 500 has not followed the traditiona...
A Bernstein Research note argues Bitcoin has likely formed a cycle bottom and pins a $450 target on Strategy stock, s...
EMB holds near the high end of its range as volatility fades, but a shift in the 10-year yield, policy signals, or EM...
Three value-focused ETFs outperformed the broad market in 2026, each using a different approach to value. AVLV, AVUV,...
Investors woke up to a surge in Qualcomm stock after the company outlined bold AI-backed growth targets. This article...
When a tech titan backs a biotech startup, investors take note. This article digs into whether Jeff Bezos backed Grai...
When tech giants join forces, investors take notice. This article breaks down the huge news nebius stock and why Meta...
As Ethereum gears up for a major tech upgrade, investors wonder if ETH is poised for a move. This guide breaks down w...